과제정보
This research was supported by the BHS Hanseo Hospital in 2019.
참고문헌
- European Centre for Disease Prevention and Control (ECDC). 2019. Carbapenem-resistant Enterobacteriaceae, second update - 26 September 2019, pp. 1-10. ECDC, Stockholm.
- Centers for Disease Control and Prevention. 2015. FAQs about choosing and implementing a CRE definition. Atlanta: Centers for Disease Control and Prevention. Available from https://www.cdc.gov/hai/organisms/cre/definition.html. Accessed Aug. 28,
- Marston HD, Dixon DM, Knisely JM, Palmore TN, Fauci AS. 2016. Antimicrobial resistance. JAMA 316: 1193-1204. https://doi.org/10.1001/jama.2016.11764
- Centers for Disease Control and Prevention (CDC). 2019. Antibiotic resistance threats in the United States, 2019, pp. 73. CDC. Atlanta (GA).
- McCann E, Srinivasan A, DeRyke CA, DePestel DD, Murray J, Gupta V. 2018. Carbapenem-nonsusceptible gram-negative pathogens in ICU and non-ICU settings in US hospitals in 2017: A multicenter study. Open Forum Infect. Dis. 5: ofy241.
- Potter RF, D'Souza AW, Dantas G. 2016. The rapid spread of carbapenem-resistant Enterobacteriaceae. Drug Resist. Updat. 29: 30-46. https://doi.org/10.1016/j.drup.2016.09.002
- Iovleva A, Doi Y. 2017. Carbapenem-resistant Enterobacteriaceae. Clin. Lab. Med. 37: 303-315. https://doi.org/10.1016/j.cll.2017.01.005
- Lee HJ, Lee DG. 2018. Carbapenem-resistant Enterobacteriaceae: recent updates and treatment strategies. J. Korean Med. Assoc. 61: 281-289. https://doi.org/10.5124/jkma.2018.61.4.281
- Kim JO, Song SA, Yoon EJ, Shin JH, Lee H, Jeong SH, et al. 2017. Outbreak of KPC-2-producing Enterobacteriaceae caused by clonal dissemination of Klebsiella pneumoniae ST307 carrying an IncX3-type plasmid harboring a truncated Tn4401a. Diagn. Microbiol. Infect. Dis. 87: 343-348. https://doi.org/10.1016/j.diagmicrobio.2016.12.012
- Jeong SH, Kim HS, Kim JS, Shin DH, Kim HS, Park MJ, et al. 2016. Prevalence and molecular characteristics of carbapenemase-producing Enterobacteriaceae from five hospitals in Korea. Ann. Lab. Med. 36: 529-535. https://doi.org/10.3343/alm.2016.36.6.529
- Korea Centers for Disease Control & Prevention (KCDC). 2019. Infectious diseases surveillance yearbook, 2019, pp. 38. Report No.: 11-1352159-000048-10. KCDC, Cheongju.
- Korea Centers for Disease Control & Prevention (KCDC). Infectious disease portal. 2020. Available from: http://www.cdc.go.kr/nptbiz/npp/ist/simple/simplePdStatsMain.do. Accessed Mar. 7, 2020.
- Korea Centers for Disease Control & Prevention (KCDC). 2018. Healthcare associated infection control guideline: VRSA/CRE. pp. 38-51. Report No.: 11-1352159-00832-10. KCDC, Cheongju.
- Centers for Disease Control and Prevention (CDC). Facility guidance for control of carbapenem-resistant Enterobacteriaceae (CRE). 2015. Available from: https://www.cdc.gov/hai/pdfs/cre/CRE-guidance-508.pdf. Accessed Mar. 7, 2020.
- Tischendorf J, de Avila RA, Safdar N. 2016. Risk of infection following colonization with carbapenem-resistant Enterobactericeae: A systematic review. Am. J. Infect. Control. 44: 539-543. https://doi.org/10.1016/j.ajic.2015.12.005
- Ho KW, Ng WT, Ip M, You JH. 2016. Active surveillance of carbapenem-resistant Enterobacteriaceae in intensive care units: Is it cost-effective in a nonendemic region? Am. J. Infect. Control. 44: 394-399. https://doi.org/10.1016/j.ajic.2015.10.026
- Poirel L, Nordmann P. 2015. Rapidec Carba NP test for rapid detection of carbapenemase producers. J. Clin. Microbiol. 53: 3003-3008. https://doi.org/10.1128/JCM.00977-15
- Clinical and Laboratory Standards Institute. 2018. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Wayne, Pennsylvania.
- Simner PJ, Martin I, Opene B, Tamma PD, Carroll KC, Milstone AM. 2016. Evaluation of multiple methods for detection of gastrointestinal colonization of carbapenem-resistant organisms from rectal swabs. J. Clin. Microbiol. 54: 1664-1667. https://doi.org/10.1128/JCM.00548-16
- Copur-Cicek A, Ozad Duzgun A, Saral A, Sandalli C. 2014. Determination of a novel integron-located variant (blaOXA-320) of Class D β-lactamase in Proteus mirabilis. J. Basic Microbiol. 54: 1030-1035. https://doi.org/10.1002/jobm.201300264
- Tsai YM, Wang S, Chiu HC, Kao CY, Wen LL. 2020. Combination of modified carbapenem inactivation method (mCIM) and EDTA-CIM (eCIM) for phenotypic detection of carbapenemase-producing Enterobacteriaceae. BMC Microbiol. 20: 315.
- van der Zwaluw K, de Haan A, Pluister GN, Bootsma HJ, de Neeling AJ, Schouls LM. 2015. The carbapenem inactivation method (CIM), a simple and low-cost alternative for the Carba NP test to assess phenotypic carbapenemase activity in gram-negative rods. PLoS One 10: e0123690.
- Jeong S, Kim JO, Jeong SH, Bae IK, Song W. 2015. Evaluation of peptide nucleic acid-mediated multiplex real-time PCR kits for rapid detection of carbapenemase genes in gram-negative clinical isolates. J. Microbiol. Methods 113: 4-9. https://doi.org/10.1016/j.mimet.2015.03.019
- Korea Centers for Disease Control and Prevention. Distribution of carbapenem-resistant Enterobacteriaceae (CRE) in Korea, 2018-2020. Available from https://www.kdca.go.kr/upload_comm/syview/doc.html?fn=163238757067000.pdf&rs=/upload_comm/docu/0034/. Accessed Mar. 11, 2022.
- Seo SM, Jeong IS. 2020. External validation of carbapenem-resistant Enterobacteriaceae acquisition risk prediction model in a medium sized hospital. J. Korean Acad. Nurs. 50: 621-630. https://doi.org/10.4040/jkan.20137
- Kim D-K, Kim HS, Pinto N, Jeon J, D'Souza R, Kim YS, et al. 2016. Xpert CARBA-R assay for the detection of carbapenemase-producing organisms in intensive care unit patients of a Korean tertiary care hospital. Ann. Lab. Med. 36: 162-165. https://doi.org/10.3343/alm.2016.36.2.162
- Peretz A, Pastukh N, Isakovich N, Koifman A, Brodsky D, Mizrahi H, et al. 2016. Efficacy of an enrichment media for increasing threshold for carbapenem-resistant Enterobacteriaceae screening. J. Clin. Lab. Anal. 30: 563-566. https://doi.org/10.1002/jcla.21903